GBL to acquire co-controlling stake in Rayner from CVC

GBL will invest €0.5 billion to acquire a co-controlling minority stake in Rayner, a global leader in surgical ophthalmology, from CVC Capital Partners VIII. The transaction was announced on February 9, 2026.

“This transaction marks an exciting milestone for Rayner.”cvc.com

• 1 source
• cvc.comGBL to invest in Rayner alongside CVC, to support growth acceleration | CVCFeb 9, 2026

Summarized from public sources; check the original articles before acting on it.